On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?

Adilson Fonseca Teixeira1, Peter ten Dijke2, Hong Zhu1
1Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Australia
2Oncode Institute and Department of Cell and Chemical Biology, Leiden University Medical Center, Netherlands

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ahmadi, 2019, Transforming growth factor-β signaling: tumorigenesis and targeting for cancer therapy., J. Cell Physiol., 234, 12173, 10.1002/jcp.27955

Anderton, 2011, Induction of heart valve lesions by small-molecule ALK5 inhibitors., Toxicol. Pathol., 39, 916, 10.1177/0192623311416259

Andres, 1992, Binding of two growth factor families to separate domains of the proteoglycan betaglycan., J. Biol. Chem., 267, 5927, 10.1016/S0021-9258(18)42643-9

Anzano, 1982, Purification by reverse-phase high-performance liquid chromatography of an epidermal growth factor-dependent transforming growth factor., Anal. Biochem., 125, 217, 10.1016/0003-2697(82)90405-5

Arteaga, 1993, Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression., J. Clin. Invest., 92, 2569, 10.1172/jci116871

2019, Cancer in Australia 2019. Cancer Series No.119. Cat. No. CAN 123.

Bai, 2019, Blocking TGF-β signaling to enhance the efficacy of immune checkpoint inhibitor., Onco. Targets Ther., 12, 9527, 10.2147/OTT.S224013

Bajwa, 2019, Adverse effects of immune checkpoint inhibitors (Programmed Death-1 Inhibitors and Cytotoxic T-Lymphocyte-Associated Protein-4 Inhibitors): results of a retrospective study., J. Clin. Med. Res., 11, 225, 10.14740/jocmr3750

Bandyopadhyay, 1999, A soluble transforming growth factor β type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells., Cancer Res., 59, 5041

Bhola, 2013, TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer., J. Clin. Invest., 123, 1348, 10.1172/JCI65416

Biswas, 2019, Exosomes produced by mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer., J. Immunol., 203, 3447, 10.4049/jimmunol.1900692

Biswas, 2011, Anti-transforming growth factor β antibody treatment rescues bone loss and prevents breast cancer metastasis to bone., PLoS One, 6, 10.1371/journal.pone.0027090

Biswas, 2008, Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells., Genes Chromosomes Cancer, 47, 95, 10.1002/gcc.20511

Biswas, 2014, Attenuation of TGF-β signaling supports tumor progression of a mesenchymal-like mammary tumor cell line in a syngeneic murine model., Cancer Lett., 346, 129, 10.1016/j.canlet.2013.12.018

Bray, 2018, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries., CA Cancer J. Clin., 68, 394, 10.3322/caac.21492

Cestari, 2012, Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles., J. Immunol., 188, 1942, 10.4049/jimmunol.1102053

Chaffer, 2006, Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2., Cancer Res., 66, 11271, 10.1158/0008-5472.can-06-2044

Chen, 2018, Live cell imaging of the TGF-β/Smad3 signaling pathway in vitro and in vivo using an adenovirus reporter system., J. Vis. Exp., 57926, 10.3791/57926

Chen, 2003, Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3., J. Exp. Med., 198, 1875, 10.1084/jem.20030152

Christianson, 2013, Cancer cell exosomes depend on cell-surface heparan sulfate proteoglycans for their internalization and functional activity., Proc. Natl. Acad. Sci. U.S.A., 110, 17380, 10.1073/pnas.1304266110

Clement, 2013, TGF-β signaling is associated with endocytosis at the pocket region of the primary cilium., Cell Rep., 3, 1806, 10.1016/j.celrep.2013.05.020

Colak, 2017, Targeting TGF-β signaling in cancer., Trends Cancer, 3, 56, 10.1016/j.trecan.2016.11.008

Cooley, 2014, Embryonic expression of the transforming growth factor beta ligand and receptor genes in chicken., Dev. Dyn., 243, 497, 10.1002/dvdy.24085

de Jonge, 1997, Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells., Oncol. Res., 9, 89

de Larco, 1978, Growth factors from murine sarcoma virus-transformed cells., Proc Natl Acad Sci U.S.A., 75, 4001, 10.1073/pnas.75.8.4001

Denney, 2015, Pulmonary epithelial cell-derived cytokine TGF-β1 is a critical cofactor for enhanced innate lymphoid cell function., Immunity, 43, 945, 10.1016/j.immuni.2015.10.012

Di Guglielmo, 2003, Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover., Nat. Cell Biol., 5, 410, 10.1038/ncb975

Dickson, 1995, Defective haematopoiesis and vasculogenesis in transforming growth factor-β 1 knock out mice., Development, 121, 1845, 10.1242/dev.121.6.1845

Dodagatta-Marri, 2019, α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas., J. Immunother. Cancer, 7, 10.1186/s40425-018-0493-9

Dutta, 2015, αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression., Biochem. J., 15, 525, 10.1042/BJ20140698

Escrevente, 2011, Interaction and uptake of exosomes by ovarian cancer cells., BMC Cancer, 11, 10.1186/1471-2407-11-108

Ferlay, 2019, Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods., Int. J. Cancer, 144, 1941, 10.1002/ijc.31937

Fitzpatrick, 1994, Transforming growth factor-beta: antisense RNA-mediated inhibition affects anchorage-independent growth, tumorigenicity and tumor-infiltrating T-cells in malignant mesothelioma., Growth Fact., 11, 29, 10.3109/08977199409015049

Flaumenhaft, 1993, Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells., J. Cell Biol., 120, 995, 10.1083/jcb.120.4.995

Fleming, 2013, SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer., Cancer Res., 73, 725, 10.1158/0008-5472.CAN-12-2706

Ganapathy, 2010, Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis., Mol. Cancer, 9, 122, 10.1186/1476-4598-9-122

Ganesh, 2018, TGF-β inhibition and immunotherapy: checkmate., Immunity, 48, 626, 10.1016/j.immuni.2018.03.037

Gao, 2012, The BMP inhibitor Coco reactivates breast cancer cells at lung metastatic sites., Cell, 150, 764, 10.1016/j.cell.2012.06.035

Gaspar, 2007, Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness., Mol. Pharmacol., 72, 152, 10.1124/mol.106.029025

Ghiringhelli, 2005, CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner., J. Exp. Med., 202, 1075, 10.1084/jem.20051511

Giampieri, 2009, Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility., Nat. Cell Biol., 11, 1287, 10.1038/ncb1973

Gladilin, 2019, TGFβ-induced cytoskeletal remodeling mediates elevation of cell stiffness and invasiveness in NSCLC., Sci. Rep., 21, 7667, 10.1038/s41598-019-43409-x

Grenga, 2018, Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis., Urol. Oncol., 36, 93.e1, 10.1016/j.urolonc.2017.09.027

Groeneveldt, 2020, Immunotherapeutic potential of TGF-β inhibition and oncolytic viruses., Trends Immunol., 41, 406, 10.1016/j.it.2020.03.003

Hachim, 2018, Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression., Tumour Biol., 40, 10.1177/1010428317748254

Hackett, 1981, The genesis of Rous sarcoma virus messenger RNAs., Virology, 112, 714, 10.1016/0042-6822(81)90316-0

Hahn, 1996, DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1., Science, 271, 350, 10.1126/science.271.5247.350

Hanahan, 2000, The hallmarks of cancer., Cell, 7, 57, 10.1016/S0092-8674(00)81683-9

Hao, 2019, TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis., Int J. Mol. Sci., 20, 10.3390/ijms20112767

Itoh, 2009, Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation., Lab. Invest., 89, 800, 10.1038/labinvest.2009.37

Itoh, 2003, Elucidation of Smad requirement in transforming growth factor-β type I receptor-induced responses., J. Biol. Chem., 278, 3751, 10.1074/jbc.m208258200

Jenkins, 2005, Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling., Nat. Med., 11, 845, 10.1038/nm1282

Karagiannis, 2013, Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1., Mol. Oncol., 7, 826, 10.1016/j.molonc.2013.04.002

Kattla, 2008, Protein kinase B/Akt activity is involved in renal TGF-β1-driven epithelial-mesenchymal transition in vitro and in vivo., Am. J. Physiol. Renal Physiol., 295, F215, 10.1152/ajprenal.00548.2007

Khatibi, , TGF-β and IL-6 family signalling crosstalk: an integrated model., Growth Fact., 35, 100, 10.1080/08977194.2017.1363746

Khatibi, , Mathematical model of TGF-β signalling: feedback coupling is consistent with signal switching., BMC Syst. Biol., 11, 10.1186/s12918-017-0421-5

Kim, 2009, Tumor self-seeding by circulating cancer cells., Cell, 139, 1315, 10.1016/j.cell.2009.11.025

Kim, 2019, RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition., Oncogene, 38, 6521, 10.1038/s41388-019-0892-5

Lebrun, 2012, The dual role of TGFβ in human cancer: from tumor suppression to cancer metastasis., ISRN Mol. Biol., 2012, 10.5402/2012/381428

Levinson, 1978, Evidence that the transforming gene of avian sarcoma virus encodes a protein kinase associated with a phosphoprotein., Cell, 15, 561, 10.1016/0092-8674(78)90024-7

Li, 2017, TGFβ1 in fibroblasts-derived exosomes promotes epithelial-mesenchymal transition of ovarian cancer cells., Oncotarget, 8, 96035, 10.18632/oncotarget.21635

Lind, 2020, Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances., J. Immunother. Cancer, 8, 10.1136/jitc-2019-000433

Liu, , Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment., Oncotarget, 7, 4122, 10.18632/oncotarget.6702

Liu, , Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways., Cancer Lett., 379, 49, 10.1016/j.canlet.2016.05.022

Liu, 2018, Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1., Cell Commun. Signal., 16, 10, 10.1186/s12964-018-0223-4

Liu, 2020, Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma., Mol. Cell Biochem., 465, 165, 10.1007/s11010-019-03676-8

López-Casillas, 1993, Betaglycan presents ligand to the TGF β signaling receptor., Cell, 73, 1435, 10.1016/0092-8674(93)90368-z

Luwor, 2015, Single live cell TGF-β signalling imaging: breast cancer cell motility and migration is driven by sub-populations of cells with dynamic TGF-β-Smad3 activity., Mol. Cancer, 4, 50, 10.1186/s12943-015-0309-1

Ma, 2007, MCP-1 mediates TGF-β-induced angiogenesis by stimulating vascular smooth muscle cell migration., Blood, 109, 987, 10.1182/blood-2006-07-036400

Mariathasan, 2018, TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells., Nature, 554, 544, 10.1038/nature25501

Matthews, 2000, Down-regulation of TGF-β1 production restores immunogenicity in prostate cancer cells., Br. J. Cancer, 83, 519, 10.1054/bjoc.2000.1257

Moore, 2014, Therapeutic targeting of integrin αvβ6 in breast cancer., J. Natl. Cancer Inst., 28, 10.1093/jnci/dju169

Mori, 2015, Enhanced expression of integrin αvβ3 induced by TGF-β is required for the enhancing effect of fibroblast growth factor 1 (FGF1) in TGF-β-induced epithelial-mesenchymal transition (EMT) in mammary epithelial cells., PLoS One, 3, 10.1371/journal.pone.0137486

Muraoka, 2002, Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases., J. Clin. Invest., 109, 1551, 10.1172/jci0215234

Nagura, 2015, Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta., Gynecol. Oncol., 136, 104, 10.1016/j.ygyno.2014.11.075

Nakao, 1997, Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling., Nature, 389, 631, 10.1038/39369

Nicolás, 2003, Attenuation of the TGF-β-Smad signaling pathway in pancreatic tumor cells confers resistance to TGF-β-induced growth arrest., Oncogene, 22, 3698, 10.1038/sj.onc.1206420

Nieto, 2016, EMT: 2016., Cell, 166, 21, 10.1016/j.cell.2016.06.028

Ostrowski, 2010, Rab27a and Rab27b control different steps of the exosome secretion pathway., Nat. Cell. Biol., 12, 19, 10.1038/ncb2000

Poggio, 2019, Suppression of exosomal PD-L1 induces systemic anti-tumor immunity and memory., Cell, 177, 414.e13, 10.1016/j.cell.2019.02.016

Rausch, 2009, An orally active small molecule TGF-β receptor I antagonist inhibits the growth of metastatic murine breast cancer., Anticancer Res., 29, 2099

Ravi, 2018, Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy., Nat. Commun., 9, 741, 10.1038/s41467-017-02696-6

Ren, 2019, Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression., Breast Cancer Res., 21, 109, 10.1186/s13058-019-1194-0

Roberts, 1981, New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues., Proc. Natl. Acad. Sci. U.S.A., 78, 5339, 10.1073/pnas.78.9.5339

Roberts, 1980, Transforming growth factors: isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction., Proc. Natl. Acad. Sci. U.S.A., 77, 3494, 10.1073/pnas.77.6.3494

Rong, 2016, Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells., Oncol. Lett., 11, 500, 10.3892/ol.2015.3841

Roth, 2013, Integrin control of the transforming growth factor-β pathway in glioblastoma., Brain, 136, 564, 10.1093/brain/aws351

Sachdeva, 2019, BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma., Sci. Rep., 9, 14569, 10.1038/s41598-019-51270-1

Sadallah, 2014, Ectosomes released by platelets induce differentiation of CD4+T cells into T regulatory cells., Thromb. Haemost., 112, 1219, 10.1160/TH14-03-0281

Sadallah, 2016, Platelet-derived ectosomes reduce NK cell function., J. Immunol., 197, 1663, 10.4049/jimmunol.1502658

Schneider, 2012, Dynamics of TGF-β induced epithelial-to-mesenchymal transition monitored by electric cell-substrate impedance sensing., Biochim. Biophys. Acta, 1813, 2099, 10.1016/j.bbamcr.2011.07.016

Seoane, 2017, TGF-β family signaling in tumor suppression and cancer progression., Cold Spring Harb. Perspect. Biol., 9, 10.1101/cshperspect.a022277

Shi, 2011, Latent TGF-β structure and activation., Nature, 474, 343, 10.1038/nature10152

Shi, 1997, A structural basis for mutational inactivation of the tumour suppressor Smad4., Nature, 388, 87, 10.1038/40431

Sorre, 2014, Encoding of temporal signals by the TGF-β pathway and implications for embryonic patterning., Dev. Cell., 30, 334, 10.1016/j.devcel.2014.05.022

Sow, 2019, Combined inhibition of TGF-β signaling and the PD-L1 immune checkpoint is differentially effective in tumor models., Cells, 8, 10.3390/cells8040320

Stehelin, 1976, DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA., Nature, 260, 170, 10.1038/260170a0

Stenvers, 2003, Heart and liver defects and reduced transforming growth factor β2 sensitivity in transforming growth factor β type III receptor-deficient embryos., Mol. Cell Biol., 23, 4371, 10.1128/mcb.23.12.4371-4385.2003

Stockis, 2017, Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8., Proc. Natl. Acad. Sci. U.S.A., 114, E10161, 10.1073/pnas.1710680114

Suzuki, 2007, A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection., Cancer Res., 67, 2351, 10.1158/0008-5472.can-06-2389

Taipale, 1994, Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein., J. Cell Biol., 124, 171, 10.1083/jcb.124.1.171

Takasaka, 2018, Integrin αvβ8-expressing tumor cells evade host immunity by regulating TGF-β activation in immune cells., JCI Insight, 3, 122591, 10.1172/jci.insight.122591

Tang, 2019, LncRNA-ATB promotes TGF-β-induced glioma cells invasion through NF-κB and P38/MAPK pathway., J. Cell Physiol., 234, 23302, 10.1002/jcp.28898

Tauriello, 2018, TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis., Nature, 554, 538, 10.1038/nature25492

Thomas, 2005, TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance., Cancer Cell, 8, 369, 10.1016/j.ccr.2005.10.012

Todaro, 1976, Transformation by murine and feline sarcoma viruses specifically blocks binding of epidermal growth factor to cells., Nature, 264, 26, 10.1038/264026a0

van Caam, 2020, TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?, Arthritis Res. Ther, 22, 42, 10.1186/s13075-020-2130-5

Vollaire, 2019, The bone morphogenetic protein signaling inhibitor LDN-193189 enhances metastasis development in mice., Front. Pharmacol., 10, 10.3389/fphar.2019.00667

Walton, 2010, Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-β1 complex., J. Biol. Chem., 285, 17029, 10.1074/jbc.M110.110288

Wang, 2014, The self-limiting dynamics of TGF-β signaling in silico and in vitro, with negative feedback through PPM1A upregulation., PLoS Comput. Biol., 10, 10.1371/journal.pcbi.1003573

Warmflash, 2012, Dynamics of TGF-β signaling reveal adaptive and pulsatile behaviors reflected in the nuclear localization of transcription factor Smad4., Proc. Natl. Acad. Sci. U.S.A., 109, E1947, 10.1073/pnas.1207607109

Webber, 2010, Cancer exosomes trigger fibroblast to myofibroblast differentiation., Cancer Res., 70, 9621, 10.1158/0008-5472.CAN-10-1722

Wegner, 2012, Dynamics and feedback loops in the transforming growth factor β signaling pathway., Biophys. Chem., 162, 22, 10.1016/j.bpc.2011.12.003

Xia, 2017, Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway., Oncotarget, 8, 37783, 10.18632/oncotarget.16354

Yang, 2016, Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma., Cancer Lett., 383, 18, 10.1016/j.canlet.2016.09.012

Yang, 2008, Abrogation of TGF β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis., Cancer Cell, 13, 23, 10.1016/j.ccr.2007.12.004

Yang, 2010, TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression., Trends Immunol., 31, 220, 10.1016/j.it.2010.04.002

Yang, 2002, Lifetime exposure to a soluble TGF-β antagonist protects mice against metastasis without adverse side effects., J. Clin. Invest., 109, 1607, 10.1172/jci200215333

Yen, 2017, Exosomal TGF-β1 is correlated with lymphatic metastasis of gastric cancers., Am. J. Cancer Res., 7, 2199

Yu, 2014, Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling., Br. J. Cancer, 110, 724, 10.1038/bjc.2013.768

Zhang, 2003, Mutational analysis of the transforming growth factor β receptor type I gene in primary non-small cell lung cancer., Lung Cancer, 40, 281, 10.1016/s0169-5002(03)00121-1

Zhang, 2011, Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma., Cancer Res., 71, 7155, 10.1158/0008-5472.CAN-11-1212

Zhang, 2007, Smad7 antagonizes transforming growth factor β signaling in the nucleus by interfering with functional Smad-DNA complex formation., Mol. Cell Biol., 27, 4488, 10.1128/mcb.01636-06

Zhong, 2010, Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells., Clin. Cancer Res., 16, 1191, 10.1158/1078-0432.CCR-09-1634

Zhou, 2014, Nuclear receptor NR4A1 promotes breast cancer invasion and metastasis by activating TGF-β signalling., Nat. Commun., 5, 3388, 10.1038/ncomms4388

Zhu, 2018, A novel TGFβ trap blocks chemotherapeutics-induced TGFβ1 signaling and enhances their anticancer activity in gynecologic cancers., Clin. Cancer Res., 24, 2780, 10.1158/1078-0432.CCR-17-3112

Zhu, 1999, A pivotal role for the transmembrane domain in transforming growth factor-β receptor activation., J. Biol. Chem., 274, 11773, 10.1074/jbc.274.17.11773

Zi, 2011, Quantitative analysis of transient and sustained transforming growth factor-β signaling dynamics., Mol. Syst. Biol., 7, 492, 10.1038/msb.2011.22